Eterna Regeneratives Raises $4 Million in Seed Funding
Eterna Regeneratives, a London-based company specializing in the development of regenerative biomaterials, has successfully secured $4 million in a seed funding round. The round was co-led by Hoxton Ventures and The Venture Collective.
Focus on Regenerative Biomaterials
Eterna Regeneratives focuses on creating biomaterials designed for mineralization and tissue regeneration. Their initial applications target oral health, specifically enamel repair, and bone regeneration. This innovative approach aims to address significant needs in dental and orthopedic healthcare.
Investment Details
The seed funding round was led by Hoxton Ventures, with participation from The Venture Collective. This investment will enable Eterna Regeneratives to further develop its technology and expand its application areas.
Strategic Use of Funds
While specific plans for the use of the funds were not detailed, it is expected that the investment will be used to accelerate product development and enhance the company's market reach in the biomaterials sector.
Location
The company is based in London, England, United Kingdom, which positions it within a vibrant ecosystem of health tech innovation.
This significant influx of capital is a promising step for Eterna Regeneratives as it aims to make strides in the regenerative medicine field.